Track Your Order Now Available on amazon
Account
logo

Understanding Diabetic Wound Care Procedure:

A Complete Guide for Patients, Caregivers & Clinicians

When a Small Cut Becomes a Life-Altering Crisis

Every 20 seconds, somewhere in the world, a lower limb is lost to diabetes. That stark statistic—published in the Wound Repair and Regeneration journal’s updated Wound Healing Society (WHS) guidelines (2024)—underscores why diabetic wound care is one of the most clinically urgent disciplines in modern medicine. For over 536 million people worldwide living with diabetes (a figure projected to reach 783 million by 2045), an unchecked blister, a friction callus on a diabetic foot, or a pressure mark on the heel can escalate into a limb-threatening diabetic foot ulcer (DFU) within days.

Introduction

India, home to the world’s second-largest diabetic population, faces a particularly acute wound care burden. Poor glycaemic control, limited access to podiatric care, and low awareness of early wound management protocols contribute to disproportionately high amputation rates. Yet, research consistently shows that up to 85% of diabetes-related amputations are preventable through timely, structured intervention and consistent diabetic foot care at home.

This guide delivers a clinically grounded, procedurally detailed walkthrough of diabetic wound care—covering diabetic foot ulcers (DFUs), pressure-induced bed sores, infection management, advanced dressings, and long-term prevention. Whether you are a patient, a family caregiver, or a healthcare professional, the insights here are drawn from the latest 2025–2026 evidence base and designed to translate directly into better outcomes.

Diabetic wound care

1. Why Diabetic Wounds Are Fundamentally Different

The Biology Behind Impaired Healing

Diabetic wound care is complex because healing is not simply “slow”—it is a cascade of molecular and cellular failures that transform ordinary tissue repair into a chronic, self-perpetuating injury cycle. At the biochemical core of the problem lies chronic hyperglycaemia, which drives several pathological processes simultaneously:

Formation of Advanced Glycation End Products (AGEs)

Diabetic wound care is complex because healing is not simply “slow”—it is a cascade of molecular and cellular failures that transform ordinary tissue repair into a chronic, self-perpetuating injury cycle. At the biochemical core of the problem lies chronic hyperglycaemia, which drives several pathological processes simultaneously:

Impaired Macrophage Polarisation:

In healthy wound healing, macrophages transition from pro-inflammatory M1 phenotypes to reparative M2 phenotypes. In diabetic tissue, this transition is disrupted—the wound remains stuck in the inflammatory phase, preventing granulation tissue formation and re-epithelialisation.

Peripheral Neuropathy:

Diabetic nerve damage eliminates the pain signals that would normally alert a patient to a developing wound. Up to 50% of people with diabetes have some degree of peripheral neuropathy, meaning a diabetic foot injury frequently goes undetected until it is deep and complicated.

Peripheral Arterial Disease (PAD):

Reduced blood flow—affecting 30–50% of people with DFUs—limits oxygen and nutrient delivery to the wound site, creating ischaemic tissue that resists standard foot ulcer treatment.

Compromised Immune Response:

Hyperglycaemia impairs neutrophil and macrophage function, reducing bacterial clearance at the wound site. This makes diabetic wounds highly susceptible to polymicrobial infections, including antibiotic-resistant organisms such as MRSA and Pseudomonas aeruginosa.
Clinical Insight: Research published in PMC (2025) confirms that HbA1c targets in the 7–8% range are optimal for DFU healing. Overly strict control (HbA1c < 7%) has not been shown to accelerate wound closure and may actually increase complication risk in complex cases.

Types of Diabetic Wounds at a Glance

Wound Type Primary Cause Key Risk Factor
Diabetic Foot Ulcers (DFUs) Neuropathy + pressure + trauma Footwear, deformity, callus
Bed Sores (Pressure Ulcers) Sustained pressure on bony prominences Immobility, poor nutrition
Ischaemic Ulcers Peripheral arterial disease Smoking, hypertension
Neuro-ischaemic Ulcers Combined neuropathy + PAD Long-standing T2DM
Charcot Foot Deformity Ulcers Bone/joint destruction from neuropathy Foot deformity, repetitive stress

2. Recognising a Diabetic Wound: Assessment and Classification

Wound Assessment: The Clinical Foundation

Effective diabetic wound care begins with systematic assessment—not just a visual inspection. A thorough evaluation drives every subsequent treatment decision and helps monitor the healing trajectory over time.

Clinicians and caregivers must check for infected diabetic wound signs such as heavy, malodorous exudate, warmth, and erythema. They should also assess the following parameters at every dressing change:

Wound Dimensions

Length × width × depth (in centimetres). A wound that is increasing in size despite treatment signals treatment failure and warrants urgent reassessment.

Wound Bed Characteristics:

Identify the percentage of granulation tissue (healthy pink/red), slough (yellow/white devitalised tissue), necrosis (black/brown dead tissue), and epithelialising tissue (new skin cells at wound edges).

Exudate Level and Type

Serous (clear), serosanguinous (blood-tinged), purulent (pus-like). Heavy, malodorous exudate is a hallmark of infection or biofilm formation.

Pain Assessment

Crucially, ischaemic wounds are often painful, while neuropathic wounds are painless. Unexpected new pain in a previously painless neuropathic ulcer may indicate infection or ischaemia.

Periwound Skin Condition

In advanced wound care, always check for maceration (overhydration from exudate), callus, erythema, warmth, and oedema—all indicators of local infection or vascular compromise.

Vascular Status

Ankle-Brachial Index (ABI) > 0.9 = normal; 0.5–0.9 = peripheral arterial disease; < 0.5 = critical ischaemia. Toe pressure measurements provide additional specificity for distal disease.

The Wagner and University of Texas Grading Systems

Two validated classification systems guide clinical decision-making. For a Grade 1 ulcer, the clinical action involves wound debridement and moist dressing to jumpstart the healing process.

Grade Description Clinical Action
Grade 0 Pre-ulcerative lesion / healed ulcer Offloading + preventive footwear
Grade 1 Superficial ulcer, no subcutaneous involvement Debridement + moist dressing
Grade 2 Deep ulcer to tendon, capsule, or bone Imaging for osteomyelitis; specialist referral
Grade 3 Deep ulcer with abscess or osteomyelitis Hospitalisation, IV antibiotics
Grade 4 Partial forefoot gangrene Vascular assessment; possible surgical intervention
Grade 5 Gangrene of the whole foot Amputation assessment

3. The Step-by-Step Diabetic Wound Care Procedure

The gold-standard diabetic wound care procedure is not a single intervention—it is a carefully sequenced, multi-step protocol that must be performed consistently at every wound management episode. The following procedure aligns with the WHS 2024 guidelines and the IWGDF 2023 consensus.

1

Hand Hygiene and Preparation

Before touching any wound in advanced wound care, thorough hand hygiene is non-negotiable. Wash hands with antiseptic soap and water for a minimum of 20 seconds, or use an alcohol-based hand rub with at least 60% isopropyl content. Wear clean disposable gloves throughout the procedure. Prepare a clean sterile field on a flat surface, laying out dressings, irrigation supplies, and any prescribed wound care products.

2

Safe Removal of the Old Dressing

Soaking dried dressings in 0.9% normal saline for 2–3 minutes before removal significantly reduces trauma and pain—a technique supported by the European Wound Management Association (EWMA). Do not forcibly peel adherent dressings; mechanical trauma to fragile granulation tissue delays re-epithelialisation by up to 72 hours. Once removed, observe the old dressing for exudate volume, colour, and odour, as this information refines your wound assessment in any diabetic wound care.

3

Wound Irrigation and Cleaning

Wound irrigation is fundamentally about mechanical removal of debris, bacteria, and necrotic tissue. The optimal technique is pulsed irrigation with normal saline or a wound-appropriate cleansing solution delivered at a pressure of 4–15 PSI using a 35 mL syringe with a 19-gauge angiocatheter. This pressure range is clinically proven to dislodge bacteria and surface biofilm without causing microtrauma to viable tissue.
Key principle: never irrigate wounds with hydrogen peroxide, povidone-iodine, or Dakin’s solution as your primary cleanser. While historically common in diabetic foot care at home, these agents are cytotoxic to fibroblasts, keratinocytes, and endothelial cells—the very cells required for wound closure. Their use is only justified in specific biofilm-dominant or necrotic wounds under specialist guidance.

4

Debridement — The Cornerstone of Chronic Wound Management

Wound debridement is the single most impactful intervention in chronic diabetic wound management. Non-viable tissue within and around the wound acts as a substrate for bacterial proliferation, inhibits growth factor activity, and physically prevents wound edge migration. The EWMA explicitly recommends radical and repeated debridement as the primary strategy for diabetic foot ulcer treatment.
There are five principal debridement methods, each with specific indications:

Sharp/Surgical Debridement:

Using sterile scissors, scalpels, or curettes to excise devitalised tissue. The fastest and most effective method, recommended for wounds with heavy slough, necrosis, or callus undermining. Requires vascular assessment before use—do not sharp-debride ischaemic wounds without revascularisation assessment.

Enzymatic Debridement:

Topical application of exogenous enzymes (e.g., collagenase) to selectively digest necrotic tissue. Useful when patients cannot tolerate surgical debridement.

Autolytic Debridement:

Harnessing the body’s own enzymes via moisture-retentive dressings (hydrocolloids, hydrogels) to soften and digest necrotic tissue. Painless and appropriate for mildly necrotic wounds in non-infected settings. Slower than surgical methods

Mechanical/Hydrotherapy:

Wet-to-dry dressings (now largely discouraged due to non-selectivity) or pulsed lavage systems. Low-frequency ultrasound is an emerging modality that disrupts biofilm effectively with minimal trauma.
Biological Debridement (Larval Therapy): Application of sterile Lucilia sericata larvae, which selectively consume necrotic tissue and secrete antimicrobial compounds. Particularly effective for sloughy wounds with complex bacterial profiles. Evidence base is growing.

5

Wound Bed Preparation Using the TIME/M.O.I.S.T. Framework

Wound bed preparation in advanced wound care is guided by two internationally recognised frameworks. The TIME framework (Tissue management, Infection/Inflammation control, Moisture balance, Edge of wound/Epithelial advancement) provides a systematic approach to optimising the chronic wound environment. The M.O.I.S.T. framework (Moisture balance, Oxygen and tissue viability, Infection/inflammation control, Support and protection, Tissue management) used by Mölnlycke and adopted by EWMA is an equivalent structured model for hard-to-heal wounds.
Applying these frameworks ensures that treatment decisions address every dimension of wound pathology—not just the visible surface.

6

Selecting the Right Dressing

Dressing selection is where wound care science meets clinical art. The ideal dressing for a diabetic wound must maintain a moist environment, manage exudate without causing maceration, protect from secondary infection, be atraumatic on removal, and not impede biological healing phases.

Dressing Type Best Suited For Key Advantage
Hydrogel Dry, necrotic wounds; autolytic debridement Donates moisture; soothes pain
Hydrocolloid Low-to-moderate exudate; granulating wounds Self-adhesive; waterproof; long wear time
Foam Dressing Moderate-to-heavy exudate management Excellent absorption; cushioning protection
Alginate Dressing Heavy exuding wounds; haemostatic need Highly absorbent; biodegradable; haemostatic
Antimicrobial (Silver/Iodine) Critically colonised or infected wounds Broad-spectrum bacterial suppression
Soft Silicone Fragile periwound skin; pain on removal Atraumatic; gentle on new epithelium
NPWT (Negative Pressure) Deep cavity wounds; post-surgical DFUs Promotes granulation; reduces oedema
Collagen/Bioactive Stalled wounds; failed standard therapy Provides scaffolding for cell migration

4. Managing Infection in Diabetic Wounds

Wound infection is the most common complication of diabetic foot ulcers and the leading precipitant of amputation. Importantly, not all colonised wounds are infected—all chronic wounds carry bacteria, but infection is only diagnosed when the bacterial load overwhelms the host’s immune defences, causing tissue damage.

Signs of Infection: Beyond the Classic Redness, Heat, Pain

In diabetic patients, classic infection signs may be blunted due to neuropathy and immunosuppression. Be alert for:

  • Increased exudate volume or change in exudate character (from clear to purulent)
  • Malodor out of proportion to wound size
  • Delayed or stalled healing despite optimised wound care
  • Wound breakdown or satellite lesions appearing around the primary wound
  • Unexplained elevation in blood glucose levels in patients with infected diabetic wound signs (a systemic marker of infection)
  • New onset of wound pain in a previously painless neuropathic ulcer
  • Systemic signs: fever, chills, elevated white cell count, rising CRP
Diabetic wound care

Biofilm: The Invisible Obstacle

Biofilm—a structured community of bacteria encased in a self-produced polymeric matrix—is present in over 90% of chronic diabetic wounds. Unlike planktonic bacteria, biofilm organisms are up to 1,000 times more resistant to antibiotics and host immune defences. Biofilm cannot be eliminated with standard antimicrobial dressings alone; it requires physical disruption through debridement, followed by sustained antimicrobial dressing therapy.

Diabetic wound care

Antibiotic Strategy

The IWGDF/IDSA 2023 guidelines recommend a staged antibiotic approach based on clinical infection severity. Mild infections (superficial, limited cellulitis < 2 cm) are treated with narrow-spectrum oral antibiotics targeting Gram-positive organisms (Staphylococcus aureus, Streptococcus spp.). Moderate-to-severe infections require broad-spectrum coverage including Gram-negative and anaerobic organisms, often with IV therapy. Duration should be as short as clinically necessary—typically 1–2 weeks for soft tissue infections and 6 weeks for confirmed osteomyelitis.

5. Diabetic Foot Ulcers: Pressure Offloading and Footwear

Offloading is widely recognised as the single most important intervention for healing plantar diabetic foot ulcers—yet it remains the most frequently overlooked component of standard care in community settings. The WHS 2024 guidelines (Level I evidence) confirm that total contact casts (TCCs) and non-removable knee-high offloading devices are the most effective offloading modalities in diabetic foot care.

Offloading Options: Evidence Ranking

1

Total Contact Cast (TCC) — Gold Standard

Distributes plantar pressure across the entire foot surface, reducing peak pressures at the ulcer site by up to 84%. Non-removable design ensures patient compliance—critical because removable devices are typically worn only 30% of the time.

2

Non-Removable Cast Boot (Instant Total Contact Cast/iTCC):

Near-equivalent to TCC in pressure reduction; can be applied by trained nurses without specialist casting skills. Preferred in high-volume community diabetic foot ulcer treatment settings.

3

Removable Cast Walker (RCW):

Effective when used; poor real-world outcomes due to adherence failures.

4

Therapeutic Footwear / Custom Insoles:

Appropriate for Grade 0–1 ulcers and as transition footwear post-healing. Essential for long-term recurrence prevention.

5

Wheelchair/Crutches:

Reserved for patients who cannot tolerate lower-leg devices due to proximal wounds or vascular compromise.

6. Bed Sores (Pressure Ulcers) in Diabetic Patients

The Dual Challenge

Pressure ulcers, popularly known as bed sores, affect an estimated 2.5 million patients in acute care settings annually. For people with diabetes, the risk is compounded: neuropathy prevents positional pain awareness, PAD limits healing capacity, and hyperglycaemia perpetuates the inflammatory wound environment.
Diabetic wound care

Common Bed Sore Sites in Diabetic Patients

Heels (the most common DFU pressure site in hospitalised patients)

Sacrum and coccyx
Lateral malleoli (ankles)
Ischial tuberosities (sitting patients)
Trochanters (hip bony prominences)

National Pressure Injury Advisory Panel (NPIAP) Staging

Stage Tissue Involvement Wound Care Approach
Stage 1 Non-blanchable erythema; intact skin Pressure relief; moisture barrier cream
Stage 2 Partial-thickness skin loss; shallow open ulcer Moist dressing (hydrocolloid/foam); reposition q2h
Stage 3 Full-thickness skin loss; subcutaneous involvement Wound Debridement; alginate/foam; consider NPWT
Stage 4 Full-thickness tissue loss; bone/tendon/muscle exposed Surgical evaluation; NPWT; systemic antibiotics
Unstageable Obscured base; slough/eschar covers the wound Debridement before accurate staging possible
Deep Tissue Injury Intact/non-intact skin; localised purple/maroon discolouration Urgent pressure relief; monitor evolution closely

Repositioning Protocol for Bed Sore Prevention

Every two hours is the minimum repositioning frequency for bed-bound patients. For those with existing pressure ulcers, a 30-degree tilt rather than a full 90-degree side-lying position reduces pressure on bony prominences while still offloading the sacrum.

High-specification reactive foam mattresses or alternating pressure mattresses significantly reduce Stage 2+ pressure injury incidence—recommended for bed sore prevention in all diabetic patients with limited mobility or existing wounds.

7. Advanced and Emerging Wound Care Therapies (2026 Updates)

The field of diabetic wound care is advancing rapidly. Several adjunctive therapies have moved from experimental to evidence-supported clinical practice, while emerging technologies promise to redefine wound healing in the next decade.

Diabetic wound care

Negative Pressure Wound Therapy (NPWT)

NPWT applies sub-atmospheric pressure (typically −75 to −125 mmHg) to the wound bed via a sealed foam dressing and vacuum pump. Clinically, Negative Pressure Wound Therapy accelerates granulation tissue formation, reduces wound oedema, removes excess exudate, and promotes angiogenesis. It is particularly effective for post-surgical DFUs, deep cavity wounds, and degloving injuries. NPWT should not be used on wounds with untreated osteomyelitis, malignant wounds, or exposed blood vessels without specialist oversight.

Diabetic wound care

Hyperbaric Oxygen Therapy (HBOT)

HBOT delivers 100% oxygen at 2–3 atmospheres absolute, saturating hypoxic wound tissues with oxygen and stimulating angiogenesis, collagen synthesis, and leucocyte bacterial killing. A landmark multicenter RCT (Snyder et al.) demonstrated that extracorporeal shock-wave therapy (ESWT) achieved complete wound closure in 37.8% of recalcitrant diabetic foot ulcers versus 26.2% for standard care alone. HBOT is indicated for Wagner Grade 3–4 DFUs with demonstrable ischaemia not amenable to revascularisation

Diabetic wound care

Bioengineered Skin Substitutes and Growth Factors

Bioengineered skin substitutes—including acellular dermal matrices (e.g., porcine small intestinal submucosa), bi-layered living skin equivalents, and autologous keratinocyte sheets—provide scaffolding and bioactive signals that support wound closure in stalled ulcers. A prospective study (Hwang et al.) demonstrated complete healing in 78.9% of chronic DFU patients treated with weekly allogeneic keratinocyte dressings, including 64.8% achieving full closure within an average of 6.1 weeks.

Diabetic wound care

Nanotechnology and Smart Wound Care (2026 Frontier)

Research published in Frontiers in Pharmacology (July 2025) highlights an extraordinary pipeline of nano-enabled diabetic wound care solutions: zinc oxide nanoparticles with antimicrobial and anti-inflammatory activity, copper carbonate NPs achieving complete wound closure in diabetic murine models by day 14, and microneedle systems co-delivering haemoglobin-resveratrol nanoparticles with glucose-metabolising gold nanowires for simultaneous blood glucose control and wound healing at the tissue level. While most remain in pre-clinical or early clinical stages, these innovations signal a paradigm shift from passive dressing to active biological intervention.

Diabetic wound care

8. The Role of Glycaemic Control in Wound Healing

While hyperglycaemia undeniably impairs wound healing through the mechanisms described in Section 1, the optimal glycaemic target for DFU management requires nuance. The latest expert panel consensus (published in Advances in Wound Care, August 2025) recommends that HbA1c targets of 7–8% represent the safest and most evidence-aligned range for DFU patients. Continuous glucose monitoring (CGM) systems—an emerging standard of care—allow real-time glycaemic tracking and have facilitated better diabetes management and wound outcomes in prospective studies.

Antihyperglycaemic agents across different classes have varying wound-healing implications. GLP-1 receptor agonists (e.g., semaglutide, liraglutide) have demonstrated anti-inflammatory and angiogenic properties beyond glycaemic control. SGLT2 inhibitors reduce cardiovascular risk and inflammation but require caution in DFU patients due to the rare risk of Fournier’s gangrene. Always coordinate wound care in diabetic foot ulcer treatment with endocrinology or diabetology input.

9. Nutritional Support for Diabetic Wound Healing

Malnutrition is a clinically underappreciated barrier to wound healing. A wound is an energetically expensive biological process—adequate macronutrient and micronutrient intake through the consumption of wound healing foods directly influences every phase of repair.

Nutrient Role in Wound Healing Food Sources / Supplementation
Protein Collagen synthesis; immune function; tissue repair Dal, paneer, eggs, lean meat; 1.2–1.5 g/kg/day for wound patients
Vitamin C Collagen cross-linking; antioxidant defence Amla, citrus, guava; 500–1000 mg/day supplement
Zinc Cell proliferation; immune function; wound closure Seeds, nuts, whole grains; 25–40 mg/day with wounds
Vitamin A Epithelialisation; immune regulation Carrots, leafy greens; 10,000 IU/day therapeutic
Omega-3 FAs Anti-inflammatory; membrane integrity Flaxseed, walnuts, fish; reduces biofilm-associated inflammation
Arginine Nitric oxide synthesis; collagen deposition Specific wound-care oral nutritional supplements

10. Prevention: The Most Powerful Wound Care Strategy

The 10-Point Diabetic Foot Prevention Protocol

1

Inspect feet daily using a mirror for the sole—check for cuts, blisters, redness, swelling, or nail changes.

2

Wash feet daily in lukewarm (not hot) water; dry gently between toes with a soft towel.

3

Apply non-alcoholic moisturiser to the dorsum and plantar surface—avoid between toes to prevent maceration.

4

Cut toenails straight across; never cut corners. Use a nail file for smoothing.

5

Never walk barefoot—indoors or outdoors. Even in the home, protective footwear prevents undetected trauma.

6

Wear properly fitted diabetic footwear with adequate toe box space; inspect the inside of shoes before wearing.

7

Attend podiatry review every 3–6 months for professional callus removal and neuropathy screening.

8

Maintain HbA1c within target range; optimize blood pressure and lipid control.

9

Focus on the intake of wound healing foods. Quit smoking—tobacco causes vasospasm that critically compromises peripheral circulation.

10

Report any new foot lesion, discolouration, or swelling to your wound care team within 24 hours.
Diabetic wound care

Conclusion:

Expertise in Every Layer of Diabetic Wound Care

Diabetic wound care is not a single procedure—it is a sustained, evidence-driven discipline that operates across biology, clinical technique, patient education, nutrition, and systemic disease management. The 20-second limb-loss statistic we opened with is not destiny; it is a preventable outcome when patients and clinicians are equipped with the right knowledge and the right tools.
From recognising the molecular basis of impaired healing to performing technically precise wound irrigation, selecting the most appropriate dressing for a specific wound bed, managing biofilm and infection, offloading plantar pressure effectively, and addressing bed sores with evidence-based repositioning—every step outlined in this guide is an opportunity to redirect a diabetic wound away from amputation and towards complete healing.
Cimidaxil is committed to advancing wound care literacy across India and to equipping healthcare professionals, patients, and caregivers with clinically grounded, practically applicable tools. Explore our full diabetic wound care product range and take the first step toward faster, safer, and more complete healing—today.

FAQ

How do I know if a diabetic wound is infected?
Classic infection signs—redness, warmth, swelling, pus—may be muted in diabetic patients due to neuropathy and immune suppression. Watch for increased or changed exudate, malodour, wound breakdown, unexplained blood sugar spikes, and new pain in a previously painless wound. If any of these are present, seek medical review within 24 hours. In diabetic wound care, do not attempt to manage suspected deep infections at home.
No—this is a critical and widespread misconception in India. Antiseptics such as povidone-iodine, chlorhexidine solutions, and hydrogen peroxide are cytotoxic to the fibroblasts and keratinocytes essential for wound healing. They should not be used as primary wound cleansers. Use only sterile normal saline or a clinically approved wound irrigation solution, and apply antimicrobial dressings only on clinical indication.
Dressing change frequency depends on wound characteristics, exudate volume, and dressing type. As a general principle, high-exudate wounds may require daily changes, while moist low-exudate wounds covered with hydrocolloid or foam dressings can remain undisturbed for 3–7 days. Overly frequent dressing changes disrupt granulation tissue and introduce infection risk. In the case of diabetic wound care, always follow your specialist’s guidance.
Yes—with appropriate, sustained multimodal care. Research indicates that structured wound care protocols can achieve complete healing in 60–80% of non-infected, adequately vascularised DFUs within 12–24 weeks. However, recurrence rates are high (approximately 40% within 1 year), emphasising that healing the ulcer is only the beginning—long-term recurrence prevention through footwear, podiatry, and glycaemic control is equally essential in foot ulcer treatment.
Diabetic foot ulcers (DFUs) typically arise from neuropathy and mechanical pressure on the plantar surface of the foot, exacerbated by deformity and reduced blood flow. Bed sores (pressure ulcers) develop from sustained external pressure on bony prominences in individuals with limited mobility—most commonly the sacrum, heels, and hips. Both are serious complications of diabetes, but their underlying pathways, assessment systems, and management priorities differ.
Hospital admission is indicated for: suspected osteomyelitis, severe systemic infection (fever, elevated WBC, bacteraemia), rapidly spreading cellulitis, critical ischaemia, Wagner Grade 3+ wounds, or failure to respond to 4 weeks of optimised outpatient wound care. Do not delay hospitalisation—delays in diagnosing ischaemia and managing deep infection are leading to legal and clinical risks in DFU management.
Nutrition is a foundational but often overlooked pillar of wound healing. Protein provides the amino acids for collagen synthesis; Vitamin C is essential for collagen cross-linking; zinc, Vitamin A, and omega-3 fatty acids modulate inflammation and immune function. Diabetic wound patients require 1.2–1.5 g of protein per kilogram of body weight per day, and nutritional supplementation should be considered in any patient with delayed healing or documented malnutrition. Focusing on the consumption of wound healing foods is of paramount importance.
Yes—several advanced therapies are gaining clinical traction in India. Negative Pressure Wound Therapy (NPWT) is now available in tertiary wound care centres. Bioengineered skin substitutes and collagen-based dressings are increasingly accessible. Smart temperature-sensing insoles (such as those developed by Siren Care, backed by Mölnlycke) predict DFU development days in advance. Additionally, nanotechnology-based topical agents containing zinc oxide and silver nanoparticles—with proven antimicrobial and anti-inflammatory activity—are entering regulated clinical markets.
Cimidaxil’s wound care products are formulated specifically for chronic and diabetic wound environments—addressing the unique challenges of high bacterial burden, tropical humidity, and complex wound exudate. Unlike standard OTC antiseptic products that harm rather than help wound tissue, Cimidaxil’s range works in harmony with the wound healing cascade.
Wound malodour is strongly associated with heavy bacterial colonisation, biofilm formation, or frank infection. Do not apply perfumed products or home remedies—these mask the symptom while allowing the underlying infection to progress. Clean the wound with normal saline, apply an antimicrobial dressing (silver-based or iodine-based as appropriate), and seek professional wound assessment within 24–48 hours. If accompanied by fever, redness spreading beyond the wound margin, or systemic unwellness, go to an emergency department immediately.